Epimedium (Horny Goat Weed) Benefits

Epimedium — 淫羊藿 yín yáng huò in Chinese, horny goat weed in English — is a genus of shade-loving woodland perennials in the barberry family, Berberidaceae. Several species are accepted as the official medicinal drug in China: Epimedium brevicornu, E. sagittatum, E. koreanum and E. pubescens. All of them are traded on the strength of one marker molecule, icariin, a prenylated flavonol glycoside.

This herb is unusual among supplements in that it has a real pharmacological story. Icariin genuinely inhibits phosphodiesterase-5 (PDE5), the same enzyme sildenafil blocks. That is not marketing; it has been measured repeatedly in purified enzyme assays. But a mechanism in a test tube and a benefit in a person are two different claims, and on this herb the distance between them is unusually wide and unusually well documented. These pages try to walk that distance honestly rather than collapse it.

The short version, before you read anything else: the best-evidenced use of Epimedium is bone, not sex. There is one 24-month randomised placebo-controlled trial in postmenopausal women with real bone-density outcomes — and even that trial tested a blend, not the herb alone. For erectile dysfunction, the endpoint the herb is actually sold for, there is no adequate human trial at all. And this product category has a documented, ongoing problem with being secretly spiked with prescription drugs, which is the single most dangerous thing on this page.

Table of Contents

  1. Deep-Dive Articles
  2. What Epimedium Actually Is
  3. The Dish-to-Person Gap
  4. Where the Evidence Is — and Is Not
  5. The Warning That Matters Most
  6. Before You Buy
  7. Key Research Papers
  8. External Resources
  9. Connections

Deep-Dive Articles

Four articles cover the herb in depth. If you are here because of the sexual-function claim, read the first one — and then read the fourth one, because the risk in this product category is not the plant.

Sexual Function and the Icariin PDE5 Question

Icariin really does inhibit PDE5 — at roughly 80 times sildenafil’s concentration, and it is undetectable in human blood after a large oral dose. The full arithmetic, the metabolite counter-argument, and why erectile dysfunction is a cardiovascular warning sign first.

Bone Density and Menopause

The one genuinely useful human trial: 100 late-postmenopausal women, 24 months, Hong Kong, real DXA outcomes. What it found, why the preparation was not pure Epimedium, and how a 1–2 percent BMD difference compares with drugs that cut fractures.

Traditional Use in Chinese Medicine

Yin yang huo as a kidney-yang tonic: the classical record, the properties and channels, the formulas it lives inside, the lamb-fat frying step that changes its chemistry — and the goat story, told once and labelled as folklore.

Safety, Adulteration and Product Quality

One analysed product line carried eight different hidden PDE5 drugs at 15–145 mg per capsule over fifteen years. Why that can be lethal with nitrates, plus the herb’s own risks: arrhythmia, liver injury, oestrogenic activity, and who must avoid it.

What Epimedium Actually Is

Gardeners in Europe and North America already know this plant. They call it barrenwort or bishop’s hat, and grow it as a tough evergreen ground cover for dry shade. The medicinal drug is the dried leaf — Herba Epimedii or Epimedii Folium in pharmacopoeial language — not the root and not the flower.

The genus contains dozens of species and China’s pharmacopoeia recognises several of them as interchangeable sources of the official drug. That is not a trivial detail. Different Epimedium species carry substantially different amounts and ratios of the active flavonoids, so “horny goat weed” on a label without a Latin binomial tells you nothing about what is in the capsule.

The chemistry, in one paragraph

Icariin is the headline compound and the standard quality marker — the number a serious product reports as a percentage. Chemically it is a prenylated flavonol glycoside: a flavonoid core, a greasy eight-carbon “prenyl” tail that helps it cross membranes, and two attached sugars. Those sugars are the problem. They make the molecule large, water-loving and poorly absorbed. In the gut, bacterial and intestinal enzymes strip them off in stages, producing icariside I, then icariside II, then the sugar-free icaritin, and finally desmethylicaritin. The plant also contains the related epimedins A, B and C, which follow similar routes.

This matters more than it sounds. When researchers gave postmenopausal women a purified Epimedium prenylflavonoid extract at 740 mg per day for six weeks and measured what actually reached the bloodstream, icariin was below the limit of detection. What circulated were the stripped-down metabolites, led by desmethylicaritin. So the compound almost every product is standardised to is not, in any meaningful sense, the compound your body is exposed to.

The Dish-to-Person Gap

The claim “icariin inhibits PDE5” is true. Here is what that sentence conceals, using only numbers from studies that measured them.

MeasurementValueSource and setting
Icariin against human PDE5A1IC50 5.9 µM (5,900 nM)Purified recombinant enzyme, Dell’Agli 2008
Sildenafil in the same assayIC50 74 nMSame paper, same conditions — about 80-fold more potent
Icariin against PDE5A1 / A2 / A3IC50 1.0 / 0.75 / 1.1 µMInsect-cell-expressed isoforms, Ning 2006 — the most favourable figures published
Zaprinast (an old, never-marketed PDE5 blocker) in that assayIC50 0.33 / 0.23 / 0.32 µMIcariin was ~3× weaker than a drug too weak to sell
Icariin in human blood after 740 mg/day of purified extractBelow detectionRandomised trial in postmenopausal women, Yong 2021
Peak blood level of the main circulating metabolite (desmethylicaritin)Median Cmax 60.9 nMSame trial — roughly 16–100× below icariin’s own IC50

Read the last two rows together. To half-block PDE5 in a tube, icariin needs somewhere between 1,000 and 5,900 nM. In people swallowing a large dose of a purified extract, icariin does not appear in blood at all, and the metabolite that does peaks near 61 nM. There is no arithmetic that turns that into an erection drug.

The fair counter-argument — and it is a real one — is that the metabolites, not icariin, are the active species, and that icariside II in particular is more potent and is detected in human serum. That is the current mainstream hypothesis in the field. But a plausible active metabolite is not a demonstrated clinical effect, and a 2026 review in Sexual Medicine Reviews concluded exactly that: the mechanistic work is broad and interesting, and clinical efficacy “still requires further confirmation in high-quality randomized controlled trials.” The full argument is laid out in the sexual-function deep dive.

Where the Evidence Is — and Is Not

UseBest available evidenceHonest verdict
Preventing bone loss after menopauseOne 24-month randomised, double-blind, placebo-controlled trial (n=100, Hong Kong) with DXA endpoints; a 6-week safety and pharmacokinetic RCT (n=58, Singapore); extensive rodent and cell workThe strongest use, and still modest. Real trial, real outcome — but the tested product also contained soy isoflavones, and no study has looked at fractures
Erectile dysfunctionEnzyme assays; rat models of diabetes, nerve injury and hypertension; no adequate randomised trial in menUnproven in humans. A genuine mechanism that has never been carried across to a clinical endpoint
Low libido, fatigue, “vitality”Traditional use; no controlled human trials isolating EpimediumTraditional indication only
Osteoarthritis, joint painStudied mostly as part of multi-herb Chinese patent formulas, where Epimedium’s own contribution cannot be separated outCannot be attributed to this herb
Cancer, neuroprotection, immune effectsCell culture and animal work on icariin and icariside IILaboratory stage. Not a human claim

One structural caveat runs through the whole table: almost all of this research comes from a single country. Chinese and Hong Kong groups have done most of the clinical work, with a Singapore group contributing the most rigorous pharmacokinetic trial. That is not an accusation — it is where the herb is used, so it is where it gets studied. But single-country evidence bases have historically been less reproducible when other groups try them, and independent replication outside East Asia has essentially not happened.

The Warning That Matters Most

If you read nothing else here, read this. “Natural male enhancement” is one of the most heavily adulterated categories in the entire supplement market, and horny goat weed is sold squarely inside it.

French analytical chemists screened 150 herbal supplements sold for sexual performance by NMR and found undeclared pharmaceuticals in a large share of them. The same group then followed one product line, marketed as a 100 percent natural aphrodisiac, from 2007 to 2022. Every single sample was tainted. Across ten samples they identified eight different adulterants — sildenafil itself, six sildenafil analogues and a vardenafil analogue — at 15 to 145 mg per capsule. Four of the samples carried at least 100 mg of PDE5 inhibitor per capsule, which is the maximum recommended single dose of prescription sildenafil. The adulterant kept changing, apparently to stay ahead of regulators’ screening tests, and the product remained on sale throughout.

This is why the risk profile of this herb is not really about the herb. Someone taking a nitrate for angina, who believes they are swallowing a mild botanical, can receive a full pharmaceutical dose of a PDE5 inhibitor. That combination causes profound, potentially fatal hypotension. The safety article covers this in full, including how to recognise a suspect product.

Before You Buy

Label elementWhat a serious product statesRed flag
SpeciesEpimedium brevicornu, E. sagittatum, E. koreanum or E. pubescens, named in Latin“Horny goat weed” with no species at all
Plant partLeaf (Herba Epimedii / Epimedii Folium)“Whole plant,” “extract,” or nothing
Marker compoundIcariin, as a percentage and as milligrams per capsule“Standardised extract” with no marker named
StrengthA number you can multiply out“10:1 extract” alone — a ratio is not a dose
Blend disclosureEach ingredient listed with its own milligram amount“Proprietary male blend 750 mg”
Third-party testingA named laboratory; certificate of analysis availableA GMP badge and nothing else
Marketing claimsRestrained and specific“Works in 30 minutes,” “rock hard,” “better than the little blue pill,” single-serve sachets at petrol stations

The last row is the one that protects you. Products that promise drug-like speed and reliability are describing a drug, and often they contain one. A real Epimedium leaf capsule cannot make you feel anything within half an hour.

Dosing, honestly

There is no evidence-based dose for any Western use of this herb, because the trials that would establish one have not been done. For context: traditional decoctions use roughly 6–15 g of dried leaf per day, boiled, and essentially always inside a multi-herb formula. The 24-month bone trial used a preparation delivering 60 mg of icariin daily alongside 15 mg daidzein and 3 mg genistein. The 6-week Singapore safety trial used 740 mg per day of a purified prenylflavonoid extract and found no liver, kidney or blood abnormalities over that period. Nothing longer or larger has been formally tested. Treat higher doses as riskier rather than stronger, and treat “more icariin” on a label as a marketing number, not a benefit.

Key Research Papers

Every identifier below was checked live against NCBI E-utilities — first author, title, journal and year all had to match before a PMID was printed. Where a claim could not be tied to a confirmed paper, it carries a PubMed topic search instead, which cannot resolve to the wrong article.

The PDE5 mechanism and its limits

  1. Dell’Agli M, Galli GV, Dal Cero E, Belluti F, Matera R, Zironi E, Pagliuca G, Bosisio E. Potent inhibition of human phosphodiesterase-5 by icariin derivatives. Journal of Natural Products. 2008;71(9):1513–1517. Icariin IC50 5.9 µM; sildenafil 74 nM in the same assay; a synthetic derivative reached 75 nM.
  2. Ning H, Xin ZC, Lin G, Banie L, Lue TF, Lin CS. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology. 2006;68(6):1350–1354. The most favourable icariin potency figures on record — still micromolar.
  3. Meng C, Jiang R. Molecular mechanisms of icariin in the treatment of erectile dysfunction. Sexual Medicine Reviews. 2026;14(3):qeag051. Current review; concludes clinical efficacy still needs confirmation in high-quality randomised trials.
  4. Shindel AW, Xin ZC, Lin G, et al. Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. The Journal of Sexual Medicine. 2010;7(4 Pt 1):1518–1528. Positive in cells and rats; not a human trial.

Pharmacokinetics — what actually reaches the blood

  1. Yong EL, Cheong WF, Huang Z, Thu WPP, Cazenave-Gassiot A, Seng KY, Logan S. Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women. Phytomedicine. 2021;91:153680. The key human pharmacokinetic study: icariin undetectable in serum after 740 mg/day.
  2. Li C, Li Q, Mei Q, Lu T. Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii. Life Sciences. 2015;126:57–68.
  3. Ding Z, Chen X, Tang D, et al. Comparisons of the bioavailability of icariin, icariside II, and epimedin C in rats after oral administration of total flavonoids of Epimedium brevicornu Maxim. and its three formulations. Journal of Pharmaceutical and Biomedical Analysis. 2025;255:116631.

Bone — the better-evidenced use

  1. Zhang G, Qin L, Shi Y. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. Journal of Bone and Mineral Research. 2007;22(7):1072–1079. The single most important human trial on this herb.
  2. Indran IR, Liang RLZ, Min TE, Yong EL. Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health. Pharmacology & Therapeutics. 2016;162:188–205.
  3. Wang Z, et al. The effect of icariin on bone metabolism and its potential clinical application. Osteoporosis International. 2018;29(3):535–544.
  4. Xiao HH, et al. Flavonoids from Herba epimedii selectively activate estrogen receptor alpha (ERα) and stimulate ER-dependent osteoblastic functions in UMR-106 cells. Journal of Steroid Biochemistry and Molecular Biology. 2014;143:141–151. The oestrogen-receptor mechanism that underlies both the bone benefit and the hormone-sensitivity caution.

Adulteration and safety

  1. Balayssac S, Danoun S, Gilard V, Martino R, Malet-Martino M. The POWER saga from 2007 to 2022: an example of a sexual enhancement dietary supplement tainted by different adulterants and still on the market. Journal of Pharmaceutical and Biomedical Analysis. 2023;227:115283. Eight adulterants, 15–145 mg per capsule, fifteen years, still on sale.
  2. Gilard V, Balayssac S, et al. Detection, identification and quantification by 1H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance. Journal of Pharmaceutical and Biomedical Analysis. 2015;102:476–493.
  3. Campbell N, Clark JP, Stecher VJ, et al. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. The Journal of Sexual Medicine. 2013;10(7):1842–1849.
  4. Partin JF, Pushkin YR. Tachyarrhythmia and hypomania with horny goat weed. Psychosomatics. 2004;45(6):536–537. The single published case report of a cardiac and mood event attributed to this herb.
  5. Wang J, Cao Y, Sun M, et al. Integrating metabolomics and bioinformatics to reveal the mechanism of Epimedium-induced liver injury. Biomedical Chromatography. 2024;38(9):e5948. Opens by stating that liver injury is the most commonly reported adverse effect of Epimedium.

Botany, tradition and chemistry

  1. Ma H, He X, Yang Y, et al. The genus Epimedium: an ethnopharmacological and phytochemical review. Journal of Ethnopharmacology. 2011;134(3):519–541. The standard reference on species, traditional uses and constituents.
  2. Qian HQ, et al. A systematic review of traditional uses, phytochemistry, pharmacology and toxicity of Epimedium koreanum Nakai. Journal of Ethnopharmacology. 2024;318(Pt B):116957.

Erectile dysfunction as a cardiovascular signal

  1. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294(23):2996–3002.
  2. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circulation: Cardiovascular Quality and Outcomes. 2013;6(1):99–109.

Live PubMed Searches

  1. Epimedium
  2. Icariin
  3. Icariside II
  4. Epimedium and erectile dysfunction
  5. Epimedium and osteoporosis
  6. Herba Epimedii
  7. Sildenafil adulteration of supplements
  8. Epimedium and liver injury

Back to Table of Contents

External Resources

Connections

Back to Table of Contents